The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets
Crossref DOI link: https://doi.org/10.1186/s12950-016-0114-7
Published Online: 2016-05-05
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lowin, Torsten
Pongratz, Georg
Straub, Rainer H.
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DE) (LO 1686/2-1)